
OS Therapies Announces Positive Data for OST-HER2 in the Treatment of Unresected Osteosarcoma in Dogs Opening the Potential for Use as Front-Line Therapy in Humans
April 10, 2025
Host Chris Miglino interviews CEO Ilan Sobel. He talks about the way that their technology is used, the challenges that they face and how they make it economically viable.